Clinical trial
Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a…
NCT00297310 · Janssen-Cilag Pty Ltd, Industry · Completed
Key facts
| NCT number | NCT00297310 |
|---|---|
| Title | Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation |
| Official title | Pre-transplant Pharmacokinetics as a Predictor of the Tacrolimus Dose Requirement Post Renal Transplantation |
| Lead sponsor | Janssen-Cilag Pty Ltd, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplantation, Transplantation |
| Intervention type | Drug |
| Interventions | tacrolimus |
| Enrollment | 89 |
| Start date | May 1, 2004 |
| Primary completion | Oct 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Feb 28, 2006 |
| Last update posted | Jun 20, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: